Now Available for Public Comment: Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials

Impact of Professional Societies' Recommendations on Practical Use of Hormone Replacement Therapy

This study has been completed.
Sponsor:
Information provided by:
Novo Nordisk A/S
ClinicalTrials.gov Identifier:
NCT01487304
First received: December 5, 2011
Last updated: May 24, 2012
Last verified: May 2012

December 5, 2011
May 24, 2012
April 2005
June 2006   (final data collection date for primary outcome measure)
Breast tenderness [ Designated as safety issue: No ]
Same as current
Complete list of historical versions of study NCT01487304 on ClinicalTrials.gov Archive Site
Patient treatment satisfaction after switch to low dose HRT [ Designated as safety issue: No ]
Same as current
Not Provided
Not Provided
 
Impact of Professional Societies' Recommendations on Practical Use of Hormone Replacement Therapy
Impact of Professional Societies Recommendations on Practical Use of Hormone Replacement Therapy - Project "WOMAN 2005"

This study is conducted in Europe. The aim of this study is to verify the therapeutic effects of low-dose hormone replacement therapy (HRT) in female patients over adequately long time period in normal clinical practice conditions in the Czech Republic.

Not Provided
Observational
Observational Model: Cohort
Time Perspective: Prospective
Not Provided
Not Provided
Probability Sample

Post-menopausal women suffering from climacteric symptoms who could benefit a switch from standard therapy to low dose therapy at the discretion of the individual physician

  • Menopause
  • Hormone Replacement Therapy, Post-Menopausal
Drug: Marketed low dose hormone replacement therapy
A low dose of marketed HRT products prescribed at the discretion of the treating physician
Low dose HRT
Intervention: Drug: Marketed low dose hormone replacement therapy
Not Provided

*   Includes publications given by the data provider as well as publications identified by ClinicalTrials.gov Identifier (NCT Number) in Medline.
 
Completed
3760
June 2006
June 2006   (final data collection date for primary outcome measure)

Inclusion Criteria:

  • Post-menopausal
Female
Not Provided
No
Contact information is only displayed when the study is recruiting subjects
Czech Republic
 
NCT01487304
KLIM-1937
No
Public Access to Clinical Trials, Novo Nordisk A/S
Novo Nordisk A/S
Not Provided
Study Director: Karel Rychna Novo Nordisk s.r.o.
Novo Nordisk A/S
May 2012

ICMJE     Data element required by the International Committee of Medical Journal Editors and the World Health Organization ICTRP